Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03723694 · ClinicalTrials.gov registry record · NA
Dietary Modulation of Neuroinflammation in Age-Related Memory Disorders
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 259
- Enrollment target
NCT03723694: Completed NA study, sponsored by Columbia University.
NCT03723694 is a NA study that has completed, run by Columbia University. The registered enrollment target is 259 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03723694, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 259 participants
- Enrollment target
Study Summary
The purpose of this study is to test the effect of a cocoa-derived dietary flavanol on brain structures and cognitive outcomes in a 12-week randomized controlled trial of 146 healthy participants, age 50-69, who will receive this cocoa derivative or a placebo. Th investigators will also examine the role of inflammation in this relationship.
Primary Outcome
circulating levels of the inflammatory marker HMGB1
Interventions
- DIETARY_SUPPLEMENT 650 mg of Cocoapro flavanols
- DIETARY_SUPPLEMENT 0 mg of Cocoapro flavanols
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 259 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2023-06-26 |
| Phase | NA |
What the finished NCT03723694 record still lists
NCT03723694 is an interventional study that assigns participants to a tested intervention. The registered 259 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which 650 mg of Cocoapro flavanols is the first listed.
NCT03723694 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03723694 about?
NCT03723694 is a clinical study titled "Dietary Modulation of Neuroinflammation in Age-Related Memory Disorders". The purpose of this study is to test the effect of a cocoa-derived dietary flavanol on brain structures and cognitive outcomes in a 12-week randomized controlled trial of 146 healthy participants, age 50-69, who will receive this cocoa derivative or a placebo. Th investigators will also examine the ...
What is the current status of trial NCT03723694?
This trial is currently completed. It is a NA study. The enrollment target is 259 participants. The study started on 2019-01-01. Estimated completion is 2023-06-26.
What interventions are being tested in trial NCT03723694?
The interventions under investigation include: 650 mg of Cocoapro flavanols (DIETARY_SUPPLEMENT), 0 mg of Cocoapro flavanols (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03723694?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03723694's enrollment target sits among peer trials
259 400th of 2000 higher than 1,599 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02361320 · 259 participants · NA
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
- NCT06797258 · 259 participants · NA
FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction
- NCT06990425 · 259 participants · NA
CLOSM Trial: Groin Closure Using Layered Option for Suture Material
- NCT07399977 · 259 participants · NA
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI